Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shervin Assassi

Showing results (221-230 of 238) with videos related to

Pageof 24
Sort By:
BMJ Open|August 10, 2013
The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease contextLinda Kwakkenbos, Lisa R Jewett, Murray Baron, et al.
Annals of the Rheumatic Diseases|August 17, 2012
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication studyLara Bossini-Castillo, Jose Ezequiel Martin, Jasper Broen, et al.
Nature Communications|November 2, 2019
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathwaysElena López-Isac, Marialbert Acosta-Herrera, Martin Kerick, et al.
Human Molecular Genetics|June 7, 2013
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility lociJose-Ezequiel Martin, Shervin Assassi, Lina-Marcela Diaz-Gallo, et al.
The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.
Human Molecular Genetics|November 15, 2011
A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populationsLara Bossini-Castillo, Jose-Ezequiel Martin, Jasper Broen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association StudiesElena López-Isac, Jose-Ezequiel Martín, Shervin Assassi, et al.
Human Molecular Genetics|March 13, 2012
Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-upJose-Ezequiel Martin, Jasper C Broen, F David Carmona, et al.
The New England Journal of Medicine|December 20, 2013
Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosisLenny van Bon, Alsya J Affandi, Jasper Broen, et al.
Best Practice & Research. Clinical Rheumatology|September 20, 2021
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SScLesley Ann Saketkoo, Tracy Frech, Cecília Varjú, et al.
Pageof 24

Showing results (221-230 of 238) with videos related to

Sort By:
Pageof 24
BMJ Open|August 10, 2013
The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease contextLinda Kwakkenbos, Lisa R Jewett, Murray Baron, et al.
Annals of the Rheumatic Diseases|August 17, 2012
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication studyLara Bossini-Castillo, Jose Ezequiel Martin, Jasper Broen, et al.
Nature Communications|November 2, 2019
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathwaysElena López-Isac, Marialbert Acosta-Herrera, Martin Kerick, et al.
Human Molecular Genetics|June 7, 2013
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility lociJose-Ezequiel Martin, Shervin Assassi, Lina-Marcela Diaz-Gallo, et al.
The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.
Human Molecular Genetics|November 15, 2011
A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populationsLara Bossini-Castillo, Jose-Ezequiel Martin, Jasper Broen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association StudiesElena López-Isac, Jose-Ezequiel Martín, Shervin Assassi, et al.
Human Molecular Genetics|March 13, 2012
Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-upJose-Ezequiel Martin, Jasper C Broen, F David Carmona, et al.
The New England Journal of Medicine|December 20, 2013
Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosisLenny van Bon, Alsya J Affandi, Jasper Broen, et al.
Best Practice & Research. Clinical Rheumatology|September 20, 2021
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SScLesley Ann Saketkoo, Tracy Frech, Cecília Varjú, et al.
Pageof 24